Trial Profile
An Evaluation of the Plasma and Urine Pharmacokinetics of Parent Compound and a Metabolite of OC000459 in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 May 2015
Price :
$35
*
At a glance
- Drugs Timapiprant (Primary)
- Indications Allergic rhinitis; Allergic rhinoconjunctivitis; Asthma; Atopic dermatitis
- Focus Pharmacokinetics
- Sponsors Atopix Therapeutics
- 22 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 16 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 23 Jan 2015 New trial record